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In Vivo 1H NMR Measurement of Glycine in Rat Brain at
9.4 T at Short Echo Time
Giulio Gambarota,* Lijing Xin, Chiara Perazzolo, Ingrid Kohler, Vladimı´r Mlyna´rik, and
Rolf Gruetter
Glycine is an amino acid present in mammalian brain, where it
acts as an inhibitory and excitatory neurotransmitter. The two
detectable protons of glycine give rise to a singlet at 3.55 ppm
that overlaps with the more intense myo-inositol resonances,
and its measurement has traditionally required speciﬁc editing
efforts. The aim of the current study was to reduce the signal
intensity of myo-inositol relative to that of glycine by exploiting
the fast signal J-evolution of the myo-inositol spin system when
using a single spin-echo localization method we recently intro-
duced. Glycine was detected at TE  20 ms with an average
Crame´r-Rao lower bound (CRLB) of 8.6%  1.5% in rat brain
(N  5), at 9.4 T. The concentration of glycine was determined
using LCModel analysis at 1.1  0.1 mM, in good agreement
with biochemical measurements previously reported. We con-
clude that at high magnetic ﬁelds, glycine can be measured at
a relatively short echo time (TE) without additional editing
efforts. Magn Reson Med 60:727–731, 2008. © 2008 Wiley-Liss,
Inc.
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Glycine is an amino acid present in mammalian brain,
where it acts as an inhibitory and excitatory neurotrans-
mitter (1). Because of its critical role in N-methyl-D-aspar-
tic acid (NMDA) transmission, altered levels of glycine are
involved in a number of pathologies. In particular, ele-
vated levels of glycine have been observed in the brain
tissues of hyperglycinemia patients and in tumors (2,3). In
a number of studies, glycine has been administered to
schizophrenia patients to improve the NMDA receptor
function, with the result of a signiﬁcant decrease in nega-
tive and cognitive symptoms (4,5). Given its importance in
mediating the action of the major excitatory neurotrans-
mitter glutamate, a direct measurement of brain glycine
concentration is desirable. The noninvasive measurement
of glycine in brain is hampered by the fact that its two-
proton singlet resonance at 3.55 ppm overlaps with the
resonances of myo-inositol, which is present in the brain at
much higher concentrations. Not surprisingly, glycine de-
tection has only been reported in the human brain, using
long TE when glycine was elevated or using additional
editing techniques, such as TE-averaged point-resolved
spectroscopy (PRESS) or 2D J-PRESS (6,7). Despite the fact
that animal studies are typically performed at high ﬁeld
strengths (7 T), where the substantial increase in SNR
and spectral resolution could allow glycine detection
without editing or TE-averaging, we are not aware of any
such report to date.
At very short TE (1–2 ms), multiplet resonances from
coupled spin systems display virtually no dephasing in-
duced by J-modulation. As TE increases, a loss of signal
intensity occurs due to J-modulation. In particular, when
using a single spin echo coherence generation at high ﬁeld,
myo-inositol undergoes rapid J-modulation due to its large
J-coupling of10 Hz. In this study we sought to reduce the
signal intensity of myo-inositol relative to that of glycine
by exploiting its J-evolution when using a single spin-echo
coherence excitation. We therefore hypothesized that it is
feasible to quantify glycine at 9.4 T in rat brain in vivo,
using a spin-echo full intensity acquired localization (SPE-
CIAL) scheme (8) at short echo times (TEs).
MATERIALS AND METHODS
Theory: Overlap of Glycine With myo-Inositol
Myo-inositol consists of six CH groups that generate a
complex spectral pattern in the 1H MR spectrum and can
be modeled as an AM2N2P spin system. The M protons
resonate at 3.52 ppm (M2), the N resonates at 3.61 ppm
(N2), and the A and P protons resonate at 4.05 and
3.27 ppm, respectively (9). In contrast, the two protons of
glycine constitute a singlet at 3.55 ppm, which overlaps
with the resonances M and N of myo-inositol. The J-cou-
pling constant between the M2 and N2 protons is J is
9.99 Hz. At 9.4 T, the ratio of the chemical shift difference
to the coupling constant for the MN coupling is 3; as a
consequence, the M and N protons are strongly coupled.
As TE increases, the J-coupling introduces a dephasing in
the M2 resonance that can be exploited for detecting the
glycine singlet.
To evaluate the potential choice of TE that allows one to
reduce the signal intensity of myo-inositol relative to that
of glycine, the spectrum of myo-inositol was simulated as
a function of TE, for a single spin-echo excitation, using
quantum-mechanics simulations based on the density ma-
trix formalism (10,11). The density matrix operator (t) for
the spin-echo excitation was written as:
(t)  RFzR, [1]
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where R  ei t H e–i TE/2 H e–i  Fy e–i TE/2 H e–i/2 Fx, and R 
ei /2 Fx ei TE/2 H ei  Fy ei TE/2 H ei t H, with H being the
Hamiltonian for the coupled spin system of myo-inositol,
and Fz, Fx, and Fy being the z, x, and y magnetic moment
operators, respectively. The transverse magnetization at
time t was found by calculating the trace of the product of
the density matrix operator with the transverse magnetic
moment operator F, where F  Fx  i Fy (11). The time
signal was generated from F for 4096 points over an
acquisition time of 1.024 s. Spectra were obtained by fast
Fourier transform of the calculated time signal, with a
line-broadening factor applied to generate singlet line-
widths that matched those observed in vivo.
MR Experiments
Experiments were performed on ﬁve healthy male Sprague
Dawley rats (320  60 g, mean  standard deviation [SD])
that were anesthetized by 1.5% to 2.0% isoﬂurane using a
nose mask. Body temperature was maintained at 37.5°C 
1°C with a circulating warm-water pad. All procedures
were performed in accordance with local and federal
guidelines and approved by the local ethics committee.
Measurements were performed on a Varian INOVA spec-
trometer (Varian, Palo Alto, CA, USA) interfaced to an
actively shielded 9.4T/31-cm magnet (Magnex Scientiﬁc,
Abingdon, UK) with actively shielded gradients (400
mT/m in 120 s, 12-cm inner diameter). An in-house-built
quadrature surface coil with two 14-mm-diameter single
loops was used as a transmitter/receiver. Gradient-echo
multislice images were acquired for anatomical localiza-
tion of the brain, to select a voxel of interest (VOI) of 2.5 	
5 	 5 mm3 centered in the hippocampus. First- and sec-
ond-order shims were adjusted for the selected VOI using
an EPI version of FASTMAP (12), resulting in a water
linewidth of 12–15 Hz. Spectra were acquired at TE  2.8
and 20 ms with the SPECIAL sequence (TR  4000 ms,
spectral width  5000 Hz, acquired complex points 
4096). The SPECIAL implementation consisted of a spin-
echo sequence with 0.5 ms 90° and 180° asymmetric slice-
selective pulses. Signal localization in the third dimension
was achieved by a 1D image-selected in vivo spectroscopy
(ISIS) approach (13), implemented with a 2-ms slice-selec-
tive adiabatic full-passage pulse applied on alternate
scans. Water signal suppression and outer volume sup-
pression was achieved as described in Ref 8. For each
experiment, a total of 160 scans were acquired in 10 sep-
arate blocks of 16 scans each. Fourier transformation and
B0 shift correction were performed prior to summation of
the 10 spectra. To analyze the dependence of the Crame´r-
Rao lower bound (CRLB) on the signal-to-noise ratio (SNR,
as estimated by the LCModel), six spectra were generated
from each experiment by averaging 16, 32, 64, 96, 128, and
160 scans, respectively. Metabolite concentrations and
CRLBs were determined by spectral data analysis per-
formed with LCModel 6.1 (14) using total creatine as an
internal reference (8 mM) for quantitation (15). In vitro
MRS experiments were performed on a pH-balanced
(pH  7.0) phantom containing 50 mM myo-inositol and
8.3 mM glycine, to approximately mimic the in vivo con-
centration ratio. Spectra were acquired at the same TEs as
in the in vivo measurements. During the experiments, the
temperature of the phantom was kept at 37°C.
RESULTS
Quantum-mechanics simulations based on the density ma-
trix formalism provided the spectral shape of myo-inositol
at different TEs. When using single spin-echo coherence
generation, the myo-inositol resonances in the 3.4–
3.7 ppm region underwent rapid J-modulation at 9.4 T,
displaying opposite phase already at TE greater than 20 ms
(Fig. 1). At short TE, the signal intensity of the combined
spectrum (myo-inositol  glycine) differed only slightly
from that of myo-inositol (Fig. 2a). Overall, the effect of the
glycine peak on the whole spectrum was mostly to slightly
broaden the M2 resonance of myo-inositol, resulting in a
very small increase of the M2 resonance height. At a TE of
20 ms, J-evolution already caused a substantial effect on
the signal intensity of myo-inositol resonances. In partic-
ular, the signal intensity of the M2 protons showed a50%
decrease due to J-modulation, and as a result the glycine
resonance was now comparable to the M2 resonance (Fig.
2b). At this TE, the combined spectrum was visually
clearly discernible from that of myo-inositol alone. More
speciﬁcally, the peak height at 3.55 ppm (which consists
of the M2 resonance of myo-inositol and glycine) ap-
proached the height of the M2 resonance at 3.51 ppm,
while in the myo-inositol spectrum the peak at 3.55 ppm
was reduced compared to the peak at 3.51 ppm. The spec-
tral pattern of the myo-inositol resonances measured in
vitro was in excellent agreement with the spectral pattern
FIG. 1. Simulated proton MR spectra of the myo-inositol reso-
nances in the 3.4–3.7 ppm region, at TE  2.8, 10, 20, 30, and
40 ms, from top to bottom, using SPECIAL excitation at 9.4 T. At
TE  20 ms, the myo-inositol signal substantially decreases due to
J-modulation, in particular at the resonance frequency of the glycine
singlet (3.55 ppm). At TEs longer than 20 ms, the myo-inositol
resonances adjacent to the glycine singlet display opposite phase.
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of simulated spectra, reproducing the characteristic asym-
metry between the height of the 3.55 and 3.51 ppm peaks
and its reduction by the presence of glycine (Fig. 2c).
At TE of 20 ms, the ﬁt of the in vivo spectrum to a basis
set that did not include the glycine peak yielded a discern-
ible ﬁt residual with positive amplitude at 3.55 ppm (Fig.
3a, middle trace). Upon inclusion of the glycine peak, the
residual at 3.55 ppm was minimized to the noise level (Fig.
3a, bottom trace). The improvement of the ﬁt is further
indicated by the arrow at the resonance frequency of gly-
cine in Fig. 3b. Glycine concentration was 1.1  0.1 mM
with an average CRLB of 8.6%  1.5% (Table 1). For the
very short TE spectrum, the mean CRLB of glycine was
33%.
The quantiﬁcation of metabolites other than glycine re-
vealed that at a TE of 20 ms, the CRLB of strongly repre-
sented metabolites increased only slightly with respect to
the values obtained at the TE of 2.8 ms. For example, the
average CRLB of glutamate was 1.4%  0.5% and 2.2% 
0.4%, at TE of 2.8 and 20 ms, respectively, corresponding
to a CRLB increase, expressed in absolute value, of less
than 1%. The increase in CRLB was 1% for myo-inositol,
creatine, and phosphocreatine; 2% for taurine; and 3% for
glutamine. There was no increase for N-acetylaspartate.
FIG. 2. Simulated (a and b) and in vitro (c) proton MR spectra of myo-inositol (thin line) and myo-inositol glycine (thick line) using SPECIAL
excitation at 9.4 T. For clarity, the glycine singlet is shown only in the left spectrum. At TE  2.8 ms, the myo-inositol  glycine spectrum
differs only slightly from the myo-inositol spectrum. At TE  20 ms, the myo-inositol signal substantially decreases due to J-modulation.
In the simulated spectra, the relaxation effect is not taken into account. The in vitro spectra display the same spectral pattern of the
myo-inositol resonances as the simulated spectra.
FIG. 3. a: In vivo proton MR spectrum (TE 20 ms) and LCModel ﬁts. Below each ﬁt the residual (enlarged 3	) is shown. The box highlights
the residual at the resonance frequency of the glycine singlet. b: Zoom in the region at 3.55 ppm of an in vivo proton MR spectrum (top)
and LCModel ﬁts without (middle) and with (bottom) glycine in the basis set. The in vivo spectrum (top) was line-broadened to match the
ﬁt (middle and bottom) obtained from the LCModel output. The arrow indicates the 3.55 ppm resonance frequency.
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For all the aforementioned metabolites, the values of the
CRLB remained below 10%. Furthermore, for the strongly
represented metabolites, the concentration estimated at
TE  20 ms was similar to that estimated at TE  2.8 ms.
In particular, at TE  2.8 and 20 ms, the concentration of
glutamate was 9.9 0.7 and 10.2 0.4, of glutamine 2.8
0.8 and 3.2  0.2, of myo-inositol 5.3  0.6 and 5.2  0.5,
of taurine 5.7 0.7 and 5.4 0.5, and of N-acetylaspartate
9.0  0.5 and 8.8  0.5 (mean  SD, N  5), respectively.
At TE of 20 ms, the CRLB of less well represented metab-
olites, such as glucose, ascorbate, and 
-aminobutyric acid
(GABA), for example, increased more substantially and to
different degrees. Other less well-represented metabolites,
such as alanine and aspartate, were not consistently de-
tected.
To evaluate the dependence of the CRLB on the SNR,
data analysis of spectra containing an increasing number
of scans was performed. At the SNR of 20 (measured for
the N-acetylaspartate singlet), the CRLB of glycine was
below 15%. For increasing SNR, the CRLB decreased,
reaching 8% at an SNR of 32 (Fig. 4).
DISCUSSION
The glycine resonance, being a singlet at 3.55 ppm that is
overlapped by the more intense myo-inositol resonances,
cannot be directly edited as has been used for coupled spin
systems such as GABA (16), but requires approaches that
minimize the signal contribution from myo-inositol. In the
present study, we show that with a TE of 20 ms it is
possible to reliably detect glycine at 9.4 T in rat brain in
vivo. With respect to the choice of TE  20 ms, this is a TE
at which the amplitude of the M2 resonance is sufﬁciently
reduced to allow for glycine detection. Compared to longer
TEs, where the M2 resonance amplitude is reduced as well,
this TE yields minimal T2 losses. Furthermore, at TE
greater than 20 ms, the myo-inositol lineshape has an
opposite phase, which could lead to partial cancellation
with the singlet of glycine. It should be noted that these
arguments apply only to the case of single spin-echo co-
herence excitation. The single spin-echo excitation yields
a decrease of the myo-inositol signal intensity that is faster
than that generated by the double spin-echo excitation, as
implemented in the commonly used PRESS. In PRESS, at
the relatively short TE of 20 ms, the closely-spaced 180°
pulses partially quench the J-modulated losses in coupled
spin systems (17), resulting in a signal dephasing that is
smaller than that induced by a single spin-echo excitation.
As a consequence, TEs longer than 20 ms may be advan-
tageous for glycine detection with a PRESS sequence.
Other approaches designed to exploit the J-modulation of
the coupled resonance, such as TE-averaged PRESS, may
not be favorable at very high ﬁeld strengths, since the
shorter T2 relaxation times of metabolites could result in
an incomplete cancellation of the outer bands of multip-
lets.
In 1H MR spectroscopy, the CRLB provides a measure of
the reliability of metabolite concentration measurements,
which in turn relies on the quality of the spectrum, in
particular the linewidth and SNR. Here we have provided
a quantitative analysis of the SNR needed to achieve a
CRLB for glycine quantitation below 10%. Even at an SNR
value of 20, the CRLB was well below 20%, supporting
the notion that the proposed approach for measuring gly-
cine provides a high reliability. The low correlation coef-
ﬁcient between glycine and myo-inositol, as estimated
from the covariance matrix by the LCModel, suggests min-
imal covariance effects at TE 20 ms. The value of glycine
concentration measured in the current study is in good
agreement with previously reported biochemical measure-
ments, where average values of concentration in adult rats
range from 1.2 to 1.6 mM (18–20). With respect to the
value of glycine concentration reported in human brain,
our result is in good agreement with the value reported by
Schulte and Boesiger (7) (Gly/Cr ratio  0.123, CRLB 
12%  3%), measured at 3 T with 2D J-PRESS. On the
other hand, both our values and those of Schulte and
Boesiger (7) are smaller than the value measured at 4 T
Table 1
Glycine and Myo-Inositol Concentration, CRLB of Glycine and Correlation Coefﬁcient Between Glycine and Myo-Inositol Measured in
Five Rats at TE  20 ms
Rat Gly (mM) Myo-Ins (mM) Gly CRLB (%) Correlation coefﬁcient
#1 1.13 5.49 8 0.009
#2 1.04 5.74 11 0.003
#3 1.00 4.66 8 0.066
#4 1.25 4.80 7 0.127
#5 1.20 5.54 9 0.029
Gly  glycine, Myo-ins  myo-inositol.
FIG. 4. CRLB as a function of the SNR. Glycine concentration was
quantiﬁed with CRLB below 10% at SNR greater than 24.
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with TE-averaged PRESS by Prescot et al. (6) (Gly*/Cr
ratio  0.03, CRLB  16%  2%, where the Gly* consists
of the glycine peak with a partial contribution from the
myo-inositol resonance). The methodology employed in
the current study could also be extended to measurements
of glycine in human brain, at ﬁeld strengths (7 T, for
instance) where sufﬁcient spectral dispersion allows for
clear separation of the M2 and N2 myo-inositol resonances.
On the other hand, since the J-modulated signal dephasing
in strongly coupled spin systems is slower with decreasing
ﬁeld strength, a TE longer than 20 ms might be favorable at
7 T to minimize the amplitude of the M2 resonance of
myo-inositol.
In animal models, several metabolites can be reliably
measured with 1H MR spectroscopy. The highest number
of metabolites is typically observed when measurements
are performed at very high ﬁeld (7 T) and at very short TE
(1–2 ms) (15). In the current study, glycine was not
consistently detected in the spectra at TE of 2.8 m, in line
with previous studies in animal models performed at very
short TE (15). The increase of TE to 20 ms, which results in
glycine detection, yields only a minor increase in the
CRLB of strongly represented metabolites. On the other
hand, less well-represented metabolites suffer to different
degrees from the extended TE of 20 ms, reducing the
ability to measure the full neurochemical proﬁle. This can,
however, still be accomplished by an additional measure-
ment at very short TE.
The J-modulation of the coupled resonance signals mea-
sured experimentally was in excellent agreement with the
quantum-mechanics simulations, as demonstrated by the
good agreement between the simulated spectra and in vitro
and in vivo results. Over the last two decades, many stud-
ies of the TE dependence of metabolite resonances have
been performed to optimize metabolite detection at the
ﬁeld strength of clinical MR scanners. On the other hand,
less attention has been paid to the TE dependence of
metabolite resonances at very high ﬁeld. The results of this
study show that also at high ﬁeld strengths, spin simula-
tions are an important tool to aid in the choice of sequence
parameters.
CONCLUSIONS
In the present study we show that it is possible to quantify
glycine at 9.4 T in rat brain in vivo, at a short TE of 20 ms,
without 2D spectroscopy or editing methods such as TE-
averaging when using single spin echo coherence genera-
tion. This provides an experimentally simple approach
that requires only a judicious choice of TE.
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